Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 4, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Dilated CardiomyopathyHeart FailureHeart Disease
Interventions
DEVICE

Mobile 6L AI-EKG Screening

"Participants (probands) with DCM will invite their first-degree relatives to undergo DCM screening procedures.~Probands and first-degree relatives will complete a mobile 6L AI-EKG which will be transmitted to a mobile app and interpreted by the AI-EKG algorithm. Results will be shared electronically or verbally to the participant.~If available, the probands clinical 12L EKGs will be obtained if recorded within 30 days of their Kardia 6L recording.~All participating FDR will be encouraged to pursue cardiac screening per ACC/AHA recommendations. Study staff will obtain echocardiogram results up to 6 months of participant enrollment."

Trial Locations (1)

17602

RECRUITING

Lancaster General Hospital, Lancaster

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mayo Clinic

OTHER

lead

Lancaster General Hospital

OTHER